Showing results (391-400 of 417) with videos related to

Sort By:
Pageof 42
Biomaterials|November 20, 2022
Tuning the 3D microenvironment of reprogrammed tubule cells enhances biomimetic modeling of polycystic kidney diseaseRoman Pichler, Ludovica Rizzo, Kevin Tröndle, et al.
Brain Communications|March 24, 2021
Implication of sestrin3 in epilepsy and its comorbiditiesFrancesca Lovisari, Paolo Roncon, Marie Soukoupova, et al.
EMBO Molecular Medicine|September 13, 2024
CRISPR-enabled point-of-care genotyping for APOL1 genetic risk assessmentRobert Greensmith, Isadora T Lape, Cristian V Riella, et al.
Genome Biology|December 14, 2016
Rare and common epilepsies converge on a shared gene regulatory network providing opportunities for novel antiepileptic drug discoveryAndree Delahaye-Duriez, Prashant Srivastava, Kirill Shkura, et al.
Epilepsia|June 11, 2019
Anticonvulsant and antiepileptogenic effects of system inactivation in chronic epilepsy modelsKarine Leclercq, Joeri Van Liefferinge, Giulia Albertini, et al.
Brain Communications|November 26, 2020
Padsevonil randomized Phase IIa trial in treatment-resistant focal epilepsy: a translational approachPierandrea Muglia, Jonas Hannestad, Christian Brandt, et al.
Toxicology|December 3, 2014
Time-dependence in mixture toxicity predictionDouglas A Dawson, Erin M G Allen, Joshua L Allen, et al.
Genome Research|March 3, 2017
Genome-wide analysis of differential RNA editing in epilepsyPrashant Kumar Srivastava, Marta Bagnati, Andree Delahaye-Duriez, et al.
Science Advances|May 26, 2023
Increased 3-O-sulfated heparan sulfate in Alzheimer's disease brain is associated with genetic risk gene HS3ST1Zhangjie Wang, Vaishali N Patel, Xuehong Song, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 22, 2025
In vivo base editing reduces liver cysts in autosomal dominant polycystic kidney diseaseAntonia Ibel, Rishi Bhardwaj, Duygu Elif Yilmaz, et al.
Pageof 42